Use of the Certificate for Pharmaceutical Products (CPP) in 18 Maturing Pharmaceutical Markets: Comparing Agency Guidelines with Company Practice

BACKGROUND: The certificate of pharmaceutical product (CPP) was implemented to accelerate the availability of new drugs in developing countries by providing evidence of the quality of products and reducing the time to market through reliance on a prior trusted analysis. However, the CPP format, issu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodier, Céline, Bujar, Magda, McAuslane, Neil, Patel, Prisha, Liberti, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785566/
https://www.ncbi.nlm.nih.gov/pubmed/32617911
http://dx.doi.org/10.1007/s43441-020-00196-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785566/
https://www.ncbi.nlm.nih.gov/pubmed/32617911
http://dx.doi.org/10.1007/s43441-020-00196-2

Ejemplares similares